Welcome to the homepage of the Institute of Cardiovascular Regeneration. Main focus of our Institute is the research and development of potential therapeutics for the treatment of cardiovascular diseases. The Institute elucidates the basic mechanisms underlying cardiovascular disease and vessel growth with the aim to develop new cellular and pharmacological therapies for improving the treatment of cardiovascular disease. Ongoing research focuses on epigenetic mechanisms that control cardiovascular repair, specifically the function of histone modifying enzymes and non-coding RNAs. Our lab is an international and interdisciplinary team consisting of independent group leaders as well as Postdocs with a medical and basic science background, PhDs and MD students and research associates.
NEWS: Research
A molecular shield against cardiac aging
Transcription factor ZBTB16 is a key regulator of endothelial and cardiac againg…
Decorin – a novel player in cardiovascular ageing
New paper from Guillermo Luxán and colleagues…
Beneficial effects of vascular endothelial growth factor B gene transfer in the aged heart
New insights into the aging heart…
NEWS: Awards & Grants
Stefanie Dimmeler receives Dr. Robert E. Beamish Award
This prestigious award honors the legacy of Dr. Robert E. Beamish, Founding Editor-in-Chief of the Canadian Journal of Cardiology…
DFG funding for Prof. Dr. Dr. Miguel Alejandre Alcazar & Dr. Julian Wagner
Awarded for research on the neuro-cardiopulmonary interface in health and aging…
Oral Presentation Award for Annika Braun
Annika Braun receives award at her very first conference…






